Journal article
Imaging in neuroendocrine tumors: an update for the clinician
International journal of endocrine oncology, Vol.2(2), pp.159-168
2015
DOI: 10.2217/ije.14.40
PMCID: PMC4526141
PMID: 26257863
Abstract
Neuroendocrine tumors are a heterogeneous group of neoplasms that are best worked up and managed using a variety of clinical and imaging studies. They are often diagnosed after they have already metastasized, though this does not necessarily preclude an attempt at curative surgical treatment or surgical debulking. Tumor burden assessment often requires use of multiple imaging modalities including computed tomography, magnetic resonance imaging and ultrasound. Somatostatin receptor-based imaging is also of great utility in looking for primaries and determining the extent of metastatic disease. This paper will review the most common imaging modalities used in the diagnosis and treatment of neuroendocrine tumors.
Details
- Title: Subtitle
- Imaging in neuroendocrine tumors: an update for the clinician
- Creators
- Jessica E Maxwell - Department of General Surgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAJames R Howe - Department of General Surgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- International journal of endocrine oncology, Vol.2(2), pp.159-168
- DOI
- 10.2217/ije.14.40
- PMID
- 26257863
- PMCID
- PMC4526141
- NLM abbreviation
- Int J Endocr Oncol
- ISSN
- 2045-0869
- eISSN
- 2045-0877
- Language
- English
- Date published
- 2015
- Academic Unit
- Surgery
- Record Identifier
- 9984051721102771
Metrics
13 Record Views